Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Kepler Cheuvreux Upgrades Vallourec to Hold

Kepler Cheuvreux upgrades Vallourec (OTC:VLOWY) from Reduce to Hold.

byBenzinga Newsdesk

July 20, 2021

1 minute read

Kepler Cheuvreux upgrades Vallourec (OTC:VLOWY) from Reduce to Hold.

SELLAS Life Sciences’s Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients

By Vandana Singh

Today, 3:36 AM

SELLAS Life Sciences Group Inc (NASDAQ:SLS) announced updated data from a Phase 1 clinical trial of galinpepimut-S (GPS), combined with Bristol-Myers Squibb…

BMY

Jefferies Maintains Buy on Elastic, Raises Price Target to $150

By Benzinga Newsdesk

Today, 3:36 AM

Jefferies analyst Brent Thill maintains Elastic (NYSE:ESTC) with a Buy and raises the price target from $135 to $150.

ESTC

Analyst Ratings

Where Triumph Bancorp Stands With Analysts

By Benzinga Insights

Today, 3:36 AM

Within the last quarter, Triumph Bancorp (NASDAQ:TBK) has observed the following analyst ratings:

TBK

Wolfe Research Initiates Coverage On SentinelOne with Outperform Rating, Announces Price Target of $52

By Benzinga Newsdesk

Today, 3:36 AM

Wolfe Research analyst Joshua Tilton initiates coverage on SentinelOne (NYSE:S) with a Outperform rating and announces Price Target of $52.

Kepler Cheuvreux Upgrades Vallourec to Hold

Related Posts

SELLAS Life Sciences’s Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients

Jefferies Maintains Buy on Elastic, Raises Price Target to $150

Where Triumph Bancorp Stands With Analysts

Wolfe Research Initiates Coverage On SentinelOne with Outperform Rating, Announces Price Target of $52